Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)
This clinical trial update describes a study evaluating fecal microbiota transplantation to reverse drug resistance in unresectable hepatoce…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study [Phase 2]
A Phase II, single-arm study evaluating the combination of TIPS and Cadonilimab for advanced hepatocellular carcinoma with tumor thrombosis-…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a GPC3-targeted CAR-T cell therapy for advanced GPC3-positive hepatocellular carcinoma; the study is n…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC
A clinical trial investigating immuno-targeted therapy with or without radiotherapy for hepatocellular carcinoma; recruitment has not yet be…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II [Phase 2]
Phase 2 IDASPHERE II evaluating idarubicin-loaded beads for chemoembolisation in hepatocellular carcinomas not amenable to interventional ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Artificially Intelligent Model for Accurate Detection of HCC
A completed Zhejiang University study evaluates an artificial intelligence model for detecting hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of JK08 for unresectable locally advanced or metastatic cancer conducted by Salubris Biotherapeutics is cur…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
Clinical trial update for TALENP002 triple therapy for intermediate-advanced hepatocellular carcinoma with bile duct tumor thrombosis; curre…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Neoadjuvant Triple Therapy for Resectable HCC
A clinical trial update on neoadjuvant triple therapy for resectable hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating safety and efficacy of telatinib in combination with pembrolizumab in advanced gastric cancer, gastroesophageal jun…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Durvalumab and Tremelimumab in Resectable HCC [Phase 2]
Phase 2 clinical trial evaluating durvalumab and tremelimumab in resectable hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma
A recruiting clinical trial investigating lipid metabolites as potential biomarkers for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients . [Phase 2]
A phase 2 clinical trial evaluating radiotherapy in combination with camrelizumab and apatinib for hepatocellular carcinoma; currently not y…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC [Phase 2]
Phase 2 clinical trial evaluating adoptive transfer of invariant natural killer T (iNKT) cells combined with TAE/TACE for unresectable hepat…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors [Phase 2]
Phase 2 trial assessing relatlimab in combination with nivolumab in advanced hepatocellular carcinoma patients who have not received prior i…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
A clinical trial update describing a study of hepatic arterial infusion chemotherapy in combination with immune checkpoint inhibitors and ty…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
This completed cross-sectional study from Pakistan measured mean alpha fetoprotein levels in patients with hepatocellular carcinoma and expl…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC
A registered clinical trial is evaluating hepatic arterial infusion chemotherapy in combination with PD-1 inhibitors and lenvatinib for inte…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.
A retrospective cohort study develops a nomogram and machine learning models to predict delayed graft function in liver transplant recipient…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
The clinical trial update indicates that radiotherapy delays the start of second-line drug therapy in patients with oligo-progressive hepato…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Meclizine for Hepatocellular Carcinoma [Phase 1]
Phase 1 clinical trial evaluating meclizine for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma [NA]
The document reports on an ongoing study evaluating early transjugular intrahepatic portosystemic shunt (TIPS) for advanced hepatocellular c…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Clinical trial update on detecting tumor cells and tumor DNA in blood, urine, and bone marrow of patients with solid cancers; the study is c…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Calculator Predicts Early Mortality Post Hepatocellular Carcinoma Resection
A clinical trial update describes a calculator that predicts early mortality after surgical resection for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related [Phase 1]
A Phase 1 clinical trial evaluating SCG101 TCR-T Cell Therapy for hepatitis B virus–related hepatocellular carcinoma is currently recruiting…